FDA Rejection Delays Regeneron From Competing With J&J, Pfizer in Multiple Myeloma

Regeneron Pharmaceuticals said the FDA cited no approvability concerns for its multiple myeloma drug, linvoseltamab, other than previously identified issues with a contract manufacturer. While linvoseltamab trails bispecific antibodies currently marketed by Johnson & Johnson and Pfizer, if approved, it could bring patients an earlier treatment option. The post FDA Rejection Delays Regeneron From Competing…

Read More

What is the “Administration for a Healthy America”?

This is a new organization that Robert F. Kennedy Jr. aims to create, consolidating the functions of many federal health organizations and cutting significant staff.  The Guardian reports: Robert F Kennedy Jr said the nation’s health agencies will cut 10,000 jobs from their 82,000-person workforce – an enormous reduction the US health secretary characterized as…

Read More

Steps or Surgery: The Case for Wearables

Relentlessly, rates of chronic disease, depression, and medication use continue to rise — if there were ever a time to implement alternative preventive health tools in clinical practice, now is certainly it.  The post Steps or Surgery: The Case for Wearables appeared first on MedCity News.

Read More

Latest Patent News In Women’s Health

The women’s health market offers enormous potential for investment and innovation. While challenges related to systemic inequalities remain, progress in venture capital funding is encouraging. Likewise, the overall increase in patent filings related to breast cancer, endometriosis, and other conditions appears to reflect a growing interest in women’s health. The post Latest Patent News In…

Read More